- Home
- CDXS vs CIK Comparison
CDXS vs CIK Comparison
Compare CDXS & CIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDXS
- CIK
- Stock Information
- Founded
- CDXS 2002
- CIK 1987
- Country
- CDXS United States
- CIK United States
- Employees
- CDXS N/A
- CIK N/A
- Industry
- CDXS Major Chemicals
- CIK Finance/Investors Services
- Sector
- CDXS Industrials
- CIK Finance
- Exchange
- CDXS Nasdaq
- CIK Nasdaq
- Market Cap
- CDXS 176.4M
- CIK 156.6M
- IPO Year
- CDXS 2010
- CIK N/A
- Fundamental
- Price
- CDXS $2.46
- CIK $2.83
- Analyst Decision
- CDXS Buy
- CIK
- Analyst Count
- CDXS 2
- CIK 0
- Target Price
- CDXS $11.00
- CIK N/A
- AVG Volume (30 Days)
- CDXS 500.7K
- CIK 115.4K
- Earning Date
- CDXS 05-14-2025
- CIK 01-01-0001
- Dividend Yield
- CDXS N/A
- CIK 9.03%
- EPS Growth
- CDXS N/A
- CIK N/A
- EPS
- CDXS N/A
- CIK N/A
- Revenue
- CDXS $59,345,000.00
- CIK N/A
- Revenue This Year
- CDXS $12.62
- CIK N/A
- Revenue Next Year
- CDXS $22.11
- CIK N/A
- P/E Ratio
- CDXS N/A
- CIK N/A
- Revenue Growth
- CDXS N/A
- CIK N/A
- 52 Week Low
- CDXS $1.90
- CIK $2.50
- 52 Week High
- CDXS $6.08
- CIK $3.19
- Technical
- Relative Strength Index (RSI)
- CDXS 51.79
- CIK 53.58
- Support Level
- CDXS $2.23
- CIK $2.81
- Resistance Level
- CDXS $2.59
- CIK $2.83
- Average True Range (ATR)
- CDXS 0.14
- CIK 0.03
- MACD
- CDXS 0.05
- CIK 0.01
- Stochastic Oscillator
- CDXS 70.45
- CIK 83.33
About CDXS Codexis Inc.
Codexis Inc is a provider of enzymatic solutions for efficient and scalable therapeutics manufacturing that leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance novel, high-performance enzymes. Codexis enzymes solve challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis' enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. Geographically, it derives maximum revenue from the Americas.
About CIK Credit Suisse Asset Management Income Fund Inc.
Credit Suisse Asset Mgmt Income Fund Inc is a closed-end management investment company. The investment objective of the fund is to provide current income consistent with the preservation of capital. Credit Suisse serves as an investment adviser for the fund. Asset Management offers a wide range of investment products and functions across asset classes and investment styles. The division manages various regional portfolios, mutual funds, and other investment vehicles for governments, institutions, corporations, and individuals.